IFF Receives All Required Antitrust Clearances for Intended Combination with DuPont’s Nutrition & Biosciences Business

IndustryPRwire -- IFF and DuPont announced that the intended combination of DuPont’s Nutrition & Biosciences (N&B) business with IFF has received unconditional clearance from the European Commission. With receipt of this clearance, the intended combination has received all required antitrust clearances and approvals that are a condition to the closing of the transaction.

IFF Chairman and CEO, Andreas Fibig Commented “We are pleased to have received our final antitrust clearance from the European Union (EU), allowing us to proceed with our combination with DuPont N&B, Having already secured the strong support of IFF’s shareholders and having made tremendous progress in our integration planning efforts, today marks another great milestone that brings us one step closer to bringing this industry-leading combination to life.”

Ed Breen, DuPont Executive Chairman and Chief Executive Officer Commneted “Both of our teams can be proud of the progress we have made during this challenging year, I am confident that, together, the combined company will be well-positioned for long-term sustainable growth.”

IFF and DuPont continue to expect to close the transaction in the first quarter of 2021.

Related Posts

Subscribe Our Newsletter